^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Romvimza (vimseltinib)

    i
    Other names: DCC-3014, DCC 3014, DCC3014
    Associations
    News
    Trials
    Company:
    Ono Pharma
    Drug class:
    CSF-1R inhibitor, FMS kinase inhibitor
    Related drugs:
    Associations
    News
    Trials